Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus diclofenac potassium premedication for mandibular molar symptomatic irreversible pulpitis
ACTRN12622000633785Phase 4Completed
- Sponsor
- Dr. Sara Bano
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketorolac and diclofenac in irreversible pulpitis (2 arms), sponsored by Dr. Sara Bano. Primary endpoints: Pain during access cavity preparation and Pain during root canal instrumentation. Started May 2022; status: completed.
02
Drugs
ketorolacdiclofenac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on ACTRN12622000633785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000633785.